The Oxford Risk Factors And Non-Invasive Imaging Study
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- University of Oxford
- Study ID
- NCT05169333
- Status
- Recruiting
Conditions
- Cardiovascular Diseases
- Cardiovascular Risk Factors
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 99 Years
- Healthy Volunteers
- Not accepted
Study Details
ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.
Key Dates
- First listed
- Dec 23, 2021
- Start date
- Feb 23, 2016
- Status verified
- Dec 2024
- Primary completion
- Feb 28, 2030
- Completion
- Feb 28, 2030
Study Design
- Enrollment
- 250,000 participants (estimated)
Arms
- Arm: Group 1Participants attending cardiology department, hypertension or outpatient clinics.
- Arm: Group 2Participants who are recruited prospectively, during their clinically indicated CT scan, and they are followed-up prospectively for clinical endpoints; A follow-up CCTA at least 6 months later will be offered to a subgroup of these patients, to assess disease progression.
- Arm: Group 3Individuals where at least 6 months have elapsed from previous CCTA will undergo repeat CCTA scan and enter prospective follow up for clinical endpoints.
- Arm: Group 4Cohort of consecutive patients who have undergone clinical CTAs or unenhanced CT chest, abdomen and pelvis in the past, linking the index CT scan with prospective outcomes collection already accumulated.
Primary Outcome Measure
Cardiac and all cause mortality [ Time Frame: 15 years ]
Central Contacts
- Kenneth Chan, Dr
- Ahmad Abdullrahman, Dr
Locations (12)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Valleywise Health | Phoenix | Arizona | - | Nordstrom, Dr |
| Yale University, School of Medicine | New Haven | Connecticut | - | Evangelos, Dr |
| Bridging Medical Silos | Tampa | Florida | - | Ho, Dr |
| Emory University | Atlanta | Georgia | - | De Cecco, Prof |
| Midwest Heart & Vascular Specialists LLC | Kansas City | Kansas | - | Bloom, Dr |
| St Luke's Hospital | Kansas City | Kansas | - | Centerp, Dr |
| NIH National Heart, Lunch, and Blood Institute | Bethesda | Maryland | - | Mehta, Dr |
| Brigham and Women's Hospital | Boston | Massachusetts | - | Blankstein, Prof |
| Cleveland Clinic | Cleveland | Ohio | - | Desai, Prof |
| UT Southwestern Medical Center | Dallas | Texas | - | Weber, Prof |
| Brooke Army Medical Center (BAMC) | San Antonio | Texas | - | Gore, Dr |
| University of Virginia | Charlottesville | Virginia | - | Villines, Prof |
Find similar trials in Phoenix, AZ
Related Studies
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)Recruiting · Brigham and Women's Hospital · Boston, Massachusetts
- BLOOM: Biological Legacy of Origin in Mother-Infant DyadsRecruiting · University of Miami · Miami, Florida
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona